Revenue
$1.54B
Fiscal year ended 2025-12-31Operating income
$310.83M
Fiscal year ended 2025-12-31Free cash flow
Unavailable
Fiscal year ended 2025-12-31Lantheus Holdings, Inc. (LNTH) reported revenue of $1.54B and net income of $233.56M for the fiscal year ended 2025-12-31. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from Lantheus Holdings, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under In Vitro & In Vivo Diagnostic Substances.
Income
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.54B | $1.53B | $1.30B | $935.06M | $425.21M | $339.41M | $347.34M | $343.37M | $331.38M | $301.85M |
| Cost of revenue | $599.66M | $545.62M | $586.89M | $353.36M | $237.51M | $200.65M | $172.53M | $168.49M | $169.24M | $164.07M |
| Gross profit | $941.95M | $988.29M | $709.54M | $581.70M | $187.70M | $138.76M | $174.81M | $174.88M | $162.14M | $137.78M |
| Operating income | $310.83M | $456.98M | $364.64M | $36.20M | -$60.82M | -$4.20M | $51.66M | $64.49M | $51.85M | $56.59M |
| Net income | $233.56M | $312.44M | $326.66M | $28.07M | -$71.28M | -$13.47M | $31.67M | $40.52M | $123.38M | Unavailable |
| Research & development | $177.31M | $168.10M | $77.71M | $311.68M | $44.97M | $32.79M | $20.02M | $17.07M | $18.12M | $12.20M |
| Weighted-average diluted shares | shares 68.44M | shares 71.65M | shares 70.24M | shares 70.67M | shares 67.49M | shares 54.13M | shares 40.11M | shares 39.50M | shares 38.89M | shares 32.66M |
| Pretax income | $313.79M | $430.98M | $410.94M | $26.72M | -$75.04M | -$11.48M | $28.63M | $49.55M | $39.64M | $28.29M |
| Income tax expense | $80.23M | $118.54M | $84.28M | -$1.35M | -$3.76M | $1.99M | -$3.04M | $9.03M | -$83.75M | $1.53M |
| Diluted EPS | $3.41 | $4.36 | $4.65 | $0.40 | $-1.06 | $-0.25 | $0.79 | $1.03 | $3.17 | $0.82 |
| Selling, general & administrative | $453.81M | $371.63M | $267.19M | $233.83M | $218.82M | $110.17M | $103.13M | $93.33M | $92.16M | $75.37M |
| General & administrative | $275.12M | $193.69M | $125.46M | $133.58M | $150.40M | $69.27M | $61.24M | $50.17M | $49.84M | $38.83M |
| Selling & marketing | $178.69M | $177.94M | $141.74M | $100.24M | $68.42M | $40.90M | $41.89M | $43.16M | $42.32M | $36.54M |
Balance
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $359.12M | $912.81M | $713.66M | $415.65M | $98.51M | $79.61M | $92.92M | $113.40M | $76.29M | $51.18M |
| Total assets | $2.23B | $1.98B | $1.65B | $1.32B | $863.78M | $869.82M | $405.92M | $439.83M | $383.86M | $255.90M |
| Current assets | $899.96M | $1.33B | $1.09B | $677.62M | $235.79M | $184.22M | $172.91M | $195.42M | $147.85M | $110.82M |
| Total liabilities | $1.14B | $892.33M | $835.26M | $874.11M | $399.34M | $355.62M | $291.32M | $368.83M | $360.57M | $362.41M |
| Current liabilities | $333.42M | $240.53M | $187.35M | $247.70M | $90.50M | $80.50M | $66.11M | $52.76M | $46.75M | $43.84M |
| Total equity incl. NCI | $1.09B | $1.09B | $815.89M | $447.15M | $464.44M | $514.20M | $114.60M | $71.00M | $23.29M | -$106.52M |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | $64.67M | $68.02M | $64.03M | $35.48M | $35.13M | $35.74M | $29.18M | $33.02M | $26.08M | $17.64M |
| Accounts receivable | $358.64M | $321.26M | $284.29M | $213.40M | $89.34M | $54.00M | $43.53M | $43.75M | $40.26M | $36.82M |
| Goodwill | $239.52M | $61.19M | $61.19M | $61.19M | $61.19M | $58.63M | $15.71M | $15.71M | $15.71M | $15.71M |
| Long-term debt | $568.68M | $565.28M | $561.67M | $557.71M | $163.12M | $197.70M | $183.93M | $263.71M | $265.39M | $274.46M |
| Accounts payable | $42.91M | $34.56M | $41.19M | $20.56M | $20.79M | $16.28M | $18.61M | $17.96M | $17.46M | $18.94M |
Cash flow
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $390.14M | $544.75M | $305.26M | $281.78M | $53.92M | $16.40M | $80.38M | $61.19M | $54.78M | $49.64M |
| Capital expenditures | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Investing cash flow | -$627.17M | -$226.02M | $5.94M | -$276.55M | $3.68M | -$4.91M | -$22.06M | -$19.13M | -$16.31M | $3.28M |
| Financing cash flow | -$316.58M | -$118.54M | -$13.06M | $311.69M | -$39.33M | -$21.86M | -$78.88M | -$4.67M | -$13.45M | -$30.22M |
| Net change in cash | -$553.66M | $199.20M | $298.04M | $316.59M | $17.96M | -$10.22M | -$20.48M | $37.11M | $25.11M | $22.58M |
| Stock-based compensation | $85.56M | $76.39M | $50.51M | $29.26M | $15.93M | $14.08M | $12.49M | $8.72M | $5.93M | $2.52M |
| Common dividends paid | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Common share repurchases | $300.02M | $100.00M | $0 | $75.00M | $0 | $0 | Unavailable | Unavailable | Unavailable | Unavailable |
| Depreciation & amortization | $70.10M | $64.62M | $60.04M | $47.93M | $42.29M | $24.69M | $13.38M | $12.77M | $18.19M | $17.33M |
Derived
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Gross margin | 61.1% | 64.4% | 54.7% | 62.2% | 44.1% | 40.9% | 50.3% | 50.9% | 48.9% | 45.6% |
| Operating margin | 20.2% | 29.8% | 28.1% | 3.9% | -14.3% | -1.2% | 14.9% | 18.8% | 15.6% | 18.7% |
| FCF margin | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| SBC / revenue | 5.6% | 5.0% | 3.9% | 3.1% | 3.7% | 4.1% | 3.6% | 2.5% | 1.8% | 0.8% |
| Current ratio | 2.70x | 5.52x | 5.80x | 2.74x | 2.61x | 2.29x | 2.62x | 3.70x | 3.16x | 2.53x |
| Revenue YoY growth | 0.5% | 18.3% | 38.6% | 119.9% | 25.3% | -2.3% | 1.2% | 3.6% | 9.8% | Unavailable |
| Net margin | 15.2% | 20.4% | 25.2% | 3.0% | -16.8% | -4.0% | 9.1% | 11.8% | 37.2% | Unavailable |
| R&D / revenue | 11.5% | 11.0% | 6.0% | 33.3% | 10.6% | 9.7% | 5.8% | 5.0% | 5.5% | 4.0% |
| CapEx / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Long-term debt / equity | 0.52x | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | 25.6% | 27.5% | 20.5% | -5.0% | Unavailable | Unavailable | -10.6% | 18.2% | -211.3% | 5.4% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open LNTH in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-08-06View SEC filing
10-Q · Filed 2026-05-07View SEC filing
10-K · Filed 2026-02-26View SEC filing
10-Q · Filed 2025-11-06View SEC filing
10-Q · Filed 2025-08-06View SEC filing
10-Q · Filed 2025-05-07View SEC filing
Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.